Back

Latham & Watkins Advises on Nexi’s €2.1 Billion Bond Offering

Latham & Watkins advised the initial purchasers on Nexi’s €2.1 billion bond offering, consisting of €1,050,000,000 Senior Notes due 2026 and €1,050,000,000 Senior Notes due 2029.

The proceeds of the Notes, together with the proceeds of the €1 billion 2028 Convertible Notes, allows Nexi to successfully prefund both the Nets Merger and the SIA Merger, extend the tenor of its debt and achieve a significant reduction in the cost of debt.

The transaction is the latest in a number of deals Latham has advised on in connection to Nexi. Most recently, the firm represented the banks on the bridge financing in connection with the merger of Nexi and Nets.

The Latham team was led by London partners Jennifer Engelhardt and Dan Maze, with associates Yeniva Massaquoi and Kathleen McCullough.

LEGAL DESIRE NEWSLETTER

Where the legal industry reads first.

Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.

No spam. Unsubscribe anytime.

From Legal Desire

Is your firm the one being cited, or the one being skipped?

We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.

Lawyers and firms: get featured on Legal Desire

Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.

Get featuredSubmit a press release
See the full deal record on DealDatabase
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
Legal Desire Press
https://legaldesire.com/about-us/
Our editorial team that covers judgments, deals, law firm updates, careers and policy across the globe. Coverage is editorially independent; sponsored posts are labeled Partner Content.

Leave a Reply